Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma-Reference-Cited by-同舟云学术

Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma

Published:2015-07-15 Issue:20 Volume:121 Page:3659-3667
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tseng William W.¹²,Zhou Shouhao³,To Christina A.⁴,Thall Peter F.³,Lazar Alexander J.⁵,Pollock Raphael E.⁶,Lin Patrick P.⁷,Cormier Janice N.⁸,Lewis Valerae O.⁷,Feig Barry W.⁸,Hunt Kelly K.⁸,Ballo Matthew T.⁹,Patel Shreyaskumar¹⁰,Pisters Peter W. T.¹¹

Affiliation:

1. Section of Surgical Oncology, Department of Surgery; Keck School of Medicine; University of Southern California; Los Angeles California

2. Sarcoma Program, Hoag Family Cancer Institute and Hoag Memorial Hospital Presbyterian; Newport Beach California

3. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Medical Oncology; Keck School of Medicine; University of Southern California; Los Angeles California

5. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Division of Surgical Oncology; James Comprehensive Cancer Center, Ohio State University; Columbus Ohio

7. Department of Orthopedic Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

8. Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

9. Department of Radiation Oncology; University of Tennessee Health Sciences Center; Memphis Tennessee

10. Department of Sarcoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

11. University Health Network; Toronto Canada

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29544/fullpdf

Reference30 articles.

1. Soft-tissue sarcomas in adults;Clark;N Engl J Med,2005

2. Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years;Penel;Ann Oncol,2011

3. Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas;Hensley;Curr Opin Oncol,2010

4. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation;Patel;J Clin Oncol,2001

5. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of Sarcoma Alliance for Research Through Collaboration Study 002;Maki;J Clin Oncol,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapidly Progressive High-Grade Leiomyosarcoma in an Elderly Patient;Cureus;2024-08-27

2. Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas;Seminars in Radiation Oncology;2024-04

3. The reporting quality and transparency of orthopaedic studies using Bayesian analysis requires improvement: A systematic review;Contemporary Clinical Trials Communications;2023-06

4. Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trials;Contemporary Clinical Trials;2023-02

5. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2022-07